Login / Signup

CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.

Hemalatha G RangarajanSara A CrowellAlison S TowermanShalini S Shenoy
Published in: Bone marrow transplantation (2022)
Keyphrases
  • sickle cell disease
  • stem cells
  • stem cell transplantation
  • cell therapy
  • bone marrow
  • hematopoietic stem cell
  • high dose
  • nk cells
  • mesenchymal stem cells